APAC’s Diversity A Key Challenge But Demand Will Keep Growing, says APACMed CEO
This article was originally published in Clinica
Executive Summary
Asia Pacific has been pegged for some time by medtech companies as a lucrative market with big growth opportunities. But the region is far from being a single homogenous market and its diversity continues to present significant challenges to both large and small players. Tina Tan speaks to Fredrik Nyberg, CEO of the recently established Asia Pacific Medical Technology Association, APACMed, to find out more about the concerns he hears from companies; what APACMed’s plans are to help address these issues; and his perspective on how the land lies for those wanting to operate in this region